# FDA recall D-0633-2022

> **STAQ Pharma, Inc.** · Class I · drug recall initiated 2022-02-03.

## Product

HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0104-05.

## Reason for recall

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

## Distribution

CO, OH, and TX.

## Key facts

- **Recall number:** D-0633-2022
- **Recalling firm:** STAQ Pharma, Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-02-03
- **Report date:** 2022-02-23
- **Termination date:** 2022-09-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Denver, CO, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0633-2022

## Citation

> AI Analytics. FDA recall D-0633-2022. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0633-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*